1. Synthesis and Biological Evaluation of (23R)- and (23S)-24,24-Difluoro-1.ALPHA.,23,25-trihydroxyvitamin D3
- Author
-
Ryuzo Hosotani, Yoichi Miyamoto, Hiroshi Iwasaki, Katsuhiro Konno, Yoshio Nakano, and Hiroaki Takayama
- Subjects
Male ,Vitamin ,Magnetic Resonance Spectroscopy ,Stereochemistry ,Vitamin D-binding protein ,medicine.medical_treatment ,Alpha (ethology) ,HL-60 Cells ,Chemical synthesis ,Calcitriol receptor ,Steroid ,Rats, Sprague-Dawley ,chemistry.chemical_compound ,Calcitriol ,Drug Discovery ,medicine ,Animals ,Humans ,Molecular Structure ,Chemistry ,Absolute configuration ,Cell Differentiation ,Biological activity ,General Chemistry ,General Medicine ,Rats ,Drug Evaluation - Abstract
The syntheses and biological evaluations of (23R)- and (23S)-24,24-difluoro-1 alpha,23,25-trithydroxyvitamin D3 (3a and 3b), new C-24 fluorinated analogs of 1 alpha,25-dihydroxyvitamin D3, are described. The syntheses of these compounds were achieved in 3 steps from (5Z,7E,20R)-1 alpha,3 beta-bis-[(tert-butyldimethylsilyl)oxy]-20-formylmethyl-9,10-seco- 5,7,10(19) pregnatriene (5) which is derived from vitamin D2. The absolute configuration at the C-23 position of 3a and 3b was determined by the modified Mosher method. The relative affinities of 3a and 3b to the vitamin D receptor were both 10 and 14 times lower than that of 1 alpha,25-dihydroxyvitamin D3 (1), and to vitamin D binding protein were also both 130 and 40 times lower. The HL-60 cell differentiating activity of 3a was 6 times more potent than that of 1, while there was no remarkable difference in activity between 3b and 1.
- Published
- 1998
- Full Text
- View/download PDF